Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment
Objective: to evaluate the effect of piribedil on cognitive functions in elderly patients with chronic cerebrovascular disease (CCVD) and cognitive impairment (CI). Patients and methods. A total of 67 patients aged 60-75 years with CCVD and CI were examined. A control group included 32 patients who...
Main Authors: | E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-12-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1217 |
Similar Items
-
FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. S. Akimova, et al.
Published: (2015-09-01) -
Cognitive and emotional impairment in patients with chronic cerebrovascular insufficiency
by: A. B. Bogolepova
Published: (2020-07-01) -
Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease
by: E. V. Yakovenko, et al.
Published: (2022-08-01) -
Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients
by: O. V. Vorobyeva, et al.
Published: (2019-06-01) -
The possibilities of diagnosing and treating cognitive impairment at non-dementia stages
by: A. Yu. Emelin
Published: (2020-10-01)